A phase 3, open-label trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2012
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- 25 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2008 New trial record.